<DOC>
	<DOCNO>NCT03029702</DOCNO>
	<brief_summary>Gestational diabetes ( GDM ) significant clinical public health burden , affect 400,000 pregnant woman United States year . Without adequate treatment , woman GDM infant risk substantial morbidity . Because , expert recommend treatment focused normalization hyperglycemia improve outcome . However , provider limit capacity predict treatment achieve glycemic goal . This result choice base provider patient preference trial error approach , create delay glycemic control within short ( 8-10 week ) window diagnosis delivery . Maternal fetal morbidity may relate mismatch glycemic pathophysiology mechanism action glucose-lowering agent . In fact , GDM heterogeneous , predominant insulin resistance ( IR ) 50 % , insulin secretion deficit ( ISD ) 30 % , combination 20 % woman underlie mechanisms hyperglycemia . This variation GDM pathophysiology clinical outcome support use individualized treatment approach . The overall goal project investigate individualized treatment approach GDM treatment base woman 's GDM mechanism . The study employ treatment arm , choice treatment differ base study arm ( match unmatched GDM mechanism ) .</brief_summary>
	<brief_title>Metabolic Analysis Treatment Choice Gestational Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Pregnancy Diabetics</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Pregnant woman beyond 24 week gestation schedule 3hour oral glucose tolerance test . Fetal anomaly Pregestational diabetes GDM diagnosis without 3hour OGTT Multifetal gestation Treatment noninhaled steroid within 7 day Allergy glyburide , metformin sulfa History severe pulmonary ( pulmonary requirement oxygen therapy daily treatment restrictive obstructive pulmonary disease ) Hepatic ( LFT 's great two time upper normal range ) Renal ( serum creatinine high 1.2 mg/dL ) disease History heart failure myocardial infarction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gestational diabetes</keyword>
	<keyword>Diabetes pregnancy</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Insulin secretion deficiency</keyword>
</DOC>